Issues of therapy of chronic non-specific lumbodynia

Low back pain or lumbalgia is one of the most common reasons for going to the doctor. Non-specific (musculoskeletal) pain is the most common (90%) cause of chronic lumbalgia. The chronic course of lumbalgia is determined not only by the anatomical sources of pain, but also by psychological and social factors that should be considered when managing patients. In the treatment of chronic nonspecific lumbalgia, a comprehensive multidisciplinary approach is effective, including optimization of drug therapy and motor activity, psychological methods (cognitive-behavioral therapy), an educational program, and manual therapy. When identifying common emotional disorders and insomnia, their therapy is required. Kinesitherapy (therapeutic gymnastics) is the most effective direction in the treatment of chronic nonspecific lumbalgia; оf primary importance are the regularity of physical exercises under the supervision of a specialist, the exclusion of sudden and excessive movements. In combination with activities, regular walking is highly effective. Cognitive-behavioral therapy is the most effective psychological direction in the management of patients with chronic nonspecific lumbalgia. It should be aimed not only at pain, but also at those often found in chronic non-specific lumbalgia insomnia, depression, and anxiety disorders. In some patients with damage to the facet joints, the sacroiliac joint, radiofrequency denervation or therapeutic blockades with anesthetics and corticosteroids can be used. Nonsteroidal anti-inflammatory drugs are used as medicines for chronic nonspecific lumbalgia, when prescribing them, it is necessary to take into account the presence and nature of risk factors for adverse events, concomitant diseases, interaction with other drugs The use of etoricoxib in chronic non-specific lumbalgia is discussed.

1. Podchufarova E.V., Yakhno N.N. Back pain. Moscow: GEHOTAR-Media; 2010. 368 p. (In Russ.)

2. Bardin L.D., King P., Maher C.G. Diagnostic triage for low back pain: a practical approach for primary care. Med J Aust. 2017;206(6):268–273. doi: 10.5694/mja16.00828.

3. Parfenov V.A., Isaykin A.I. Pain in the lumbar region. Moscow: Moskva; 2018. 200 p. (In Russ.)

4. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. doi: 10.1016/S0140-6736(15)60692-4.

5. Qaseem A., Wilt T.J., McLean R.M., Forciea M.A. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2017;166(7):514–530. doi: 10.7326/M16-2367.

6. Kamper S.J., Apeldoorn A.T., Chiarotto A., Smeets R.J., Ostelo R.W., Guzman J., van Tulder M.W. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ. 2015;350:h444. doi: 10.1136/bmj.h444.

7. Parfenov V.A., Yakhno N.N., Davydov O.S., Kukushkin M.L., Churyukanov M.V., Golovacheva V.A. et al. Chronic nonspecific (musculoskeletal) low back pain. Guidelines of the Russian Society for the Study of Pain (RSSP). Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(2S):7–16. (In Russ.) doi: 10.14412/2074-2711-2019-2S-7-16.

8. Clinical Guidelines. Low Back Pain and Sciatica in Over 16s: Assessment and Management. London: National Institute for Health and Care Excellence (UK); 2016. Available at: www.nice.org.uk/guidance/ng59.

9. Chou R., Deyo R., Friedly J., Skelly A., Hashimoto R., Weimer M. et al. Nonpharmacologic therapies for low back pain: a systematic review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2017;166(7):493–505. doi: 10.7326/M16-2459.

10. Bahouq H., Allali F., Rkain H., Hmamouchi I., Hajjaj-Hassouni N. Prevalence and severity of insomnia in chronic low back pain patients. Rheumatol Int. 2013;33(5):1277–1281. doi: 10.1007/s00296-012-2550-x.

11. Marty M., Rozenberg S., Duplan B., Thomas P., Duquesnoy B., Allaert F. Quality of sleep in patients with chronic low back pain: a case-control study. Eur Spine J. 2008;17(6):839–844. doi: 10.1007/s00586-008-0660-7.

12. Tang N.K., Lereya S.T., Boulton H., Miller M.A., Wolke D., Cappuccio F.P. Nonpharmacological treatments of insomnia for long-term painful conditions: a systematic review and meta-analysis of patient-reported outcomes in randomized controlled trials. Sleep. 2015;38(11):1751–1764. doi: 10.5665/sleep.5158.

13. van Middelkoop M., Rubinstein S.M., Verhagen A.P., Ostelo R.W., Koes B.W., van Tulder M.W. Exercise therapy for chronic nonspecific low-back pain. Best Pract Res Clin Rheumatol. 2010;24(2):193–204. doi: 10.1016/j.berh.2010.01.002.

14. Yamato T.P., Maher C.G., Saragiotto B.T., Hancock M.J., Ostelo R.W., Cabral C.M. et al. Pilates for low back pain. Cochrane Database Syst Rev. 2015;(7):CD010265. doi: 10.1002/14651858.CD010265.pub2.

15. Pillastrini P., Ferrari S., Rattin S., Cupello A., Villafañe J.H., Vanti C. Exercise and tropism of the multifidus muscle in low back pain: a short review. J Phys Ther Sci. 2015;27(3):943–945. doi: 10.1589/jpts.27.943.

16. O’Connor S.R., Tully M.A., Ryan B., Bleakley C.M., Baxter G.D., Bradley J.M., McDonough S.M. Walking exercise for chronic musculoskeletal pain: systematic review and meta-analysis. Arch Phys Med Rehabil. 2015;96(4):724–

17. e3. doi: 10.1016/j.apmr.2014.12.003.

18. Hendrick P., Te Wake A.M., Tikkisetty A.S., Wulff L., Yap C., Milosavljevic S. The effectiveness of walking as an intervention for low back pain: a systematic review. Eur Spine J. 2010;19(10):1613–1620. doi: 10.1007/s00586-010-1412-z.

19. Henschke N., Ostelo R.W., van Tulder M.W., Vlaeyen J.W., Morley S., Assendelft W.J., Main C.J. Behavioural treatment for chronic low-back pain. Cochrane Database Syst Rev. 2010;2010(7):CD002014. doi: 10.1002/14651858.CD002014.pub3.

20. Richmond H., Hall A.M., Copsey B., Hansen Z., Williamson E., Hoxey- Thomas N. et al. The effectiveness of cognitive behavioural treatment for non-specific low back pain: a systematic review and metaanalysis. PLoS One. 2015;10(8):e0134192. doi: 10.1371/journal.pone.0134192.

21. Knoerl R., Lavoie Smith E.M., Weisberg J. Chronic Pain and Cognitive Behavioral Therapy: An Integrative Review. West J Nurs Res. 2016;38(5):596–628. doi: 10.1177/0193945915615869.

22. Vibe Fersum K., O’Sullivan P., Skouen J.S., Smith A., Kvåle A. Efficacy of classification-based cognitive functional therapy in patients with nonspecific chronic low back pain: a randomized controlled trial. Eur J Pain. 2013;17(6):916–928. doi: 10.1002/j.1532-2149.2012.00252.x.

23. Cherkin D.C., Sherman K.J., Balderson B.H., Cook A.J., Anderson M.L., Hawkes R.J. et al. Effect of Mindfulness-Based Stress Reduction vs Cognitive Behavioral Therapy or Usual Care on Back Pain and Functional Limitations in Adults With Chronic Low Back Pain: A Randomized Clinical Trial. JAMA. 2016;315(12):1240–1249. doi: 10.1001/jama.2016.2323.

24. Khabirov F.A., Khabirova Yu.F. Pain in the neck and back: a guide for doctors. Kazan: Meditsina; 2014. 504 p. (In Russ.)

25. Rubinstein S.M., de Zoete A., van Middelkoop M., Assendelft W.J.J., de Boer M.R., van Tulder M.W. Benefits and harms of spinal manipulative therapy for the treatment of chronic low back pain: systematic review and meta-analysis of randomised controlled trials. BMJ. 2019;364:l689. doi: 10.1136/bmj.l689.

26. Hutchinson A.J., Ball S., Andrews J.C., Jones G.G. The effectiveness of acupuncture in treating chronic non-specific low back pain: a systematic review of the literature. J Orthop Surg Res. 2012;7:36. doi: 10.1186/1749-799X-7-36.

27. Liu L., Skinner M., McDonough S., Mabire L., Baxter G.D. Acupuncture for low back pain: an overview of systematic reviews. Evid Based Complement Alternat Med. 2015;2015:328196. doi: 10.1155/2015/328196.

28. Furlan A.D., Giraldo M., Baskwill A., Irvin E., Imamura M. Massage for lowback pain. Cochrane Database Syst Rev. 2015;(9):CD001929. doi: 10.1002/14651858.CD001929.pub3.

29. Kuritzky L., Samraj G.P. Nonsteroidal anti-inflammatory drugs in the treatment of low back pain. J Pain Res. 2012;5:579–590. doi: 10.2147/JPR.S6775.

30. Enthoven W.T., Roelofs P.D., Deyo R.A., van Tulder M.W., Koes B.W. Nonsteroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016;2(2):CD012087. doi: 10.1002/14651858.CD012087.

31. Karateev A.E. Etoricoxib can be used for chronic nonspecific back pain: a new indication of the well-known drug. Nevrologiya, neyropsikhiatriya, psikReferences hosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(2):125–130. (In Russ.) doi: 10.14412/2074-2711-2020-2-125-130.

32. Birbara C.A., Puopolo A.D., Muñoz D.R., Sheldon E.A., Mangione A., Bohidar N.R., Geba G.P. Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability – a randomized, placebo-controlled, 3-month trial. J Pain. 2003;4(6):307–315. doi: 10.1016/s1526-5900(03)00633-3.

33. Pallay R.M., Seger W., Adler J.L., Ettlinger R.E., Quaidoo E.A., Lipetz R. et al. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scand J Rheumatol. 2004;33(4):257–266. doi: 10.1080/03009740410005728.

34. Zerbini C., Ozturk Z.E., Grifka J., Maini M., Nilganuwong S., Morales R. et al. Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study. Curr Med Res Opin. 2005;21(12):2037–2049. doi: 10.1185/030079905X75069.

35. Lin H.Y., Cheng T.T., Wang J.H., Lee C.S., Chen M.H., Lei V. et al. Etoricoxib improves pain, function and quality of life: results of a real-world effectiveness trial. Int J Rheum Dis. 2010;13(2):144–150. doi: 10.1111/j.1756-185X.2010.01468.x.

36. Moss P., Benson H.A.E., Will R., Wright A. Fourteen days of etoricoxib 60 mg improves pain, hyperalgesia and physical function in individuals with knee osteoarthritis: a randomized controlled trial. Osteoarthritis Cartilage. 2017;25(11):1781–1791. doi: 10.1016/j.joca.2017.07.009.

37. Arendt-Nielsen L., Egsgaard L.L., Petersen K.K. Evidence for a central mode of action for etoricoxib (COX-2 inhibitor) in patients with painful knee osteoarthritis. Pain. 2016;157(8):1634–1644. doi: 10.1097/j.pain.0000000000000562.

38. Parfyonov V.A., Antonenko L.M., Lebedeva N.V. Management of patients with acute lumbodynia and lumbar ischialgia in outpatient settings. Meditsinskiy sovet = Medical Council. 2016;(8):38–43. (In Russ.) doi: 10.21518/2079-701X-2016-8-38-43.

39. van Tulder M.W., Touray T., Furlan A.D., Solway S., Bouter L.M. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev. 2003;2003(2):CD004252. doi: 10.1002/14651858.CD004252.

40. Staiger T.O., Gaster B., Sullivan M.D., Deyo R.A. Systematic review of antidepressants in the treatment of chronic low back pain. Spine (Phila Pa 1976). 2003;28(22):2540–2545. doi: 10.1097/01.BRS.0000092372.73527.BA.

41. Kuijpers T., van Middelkoop M., Rubinstein S.M., Ostelo R., Verhagen A., Koes B.W., van Tulder M.W. A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain. Eur Spine J. 2011;20(1):40–50. doi: 10.1007/s00586-010-1541-4.

42. Skljarevski V., Zhang S., Desaiah D., Alaka K.J., Palacios S., Miazgowski T., Patrick K. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blindtrial. J Pain. 2010;11(12):1282–1290. doi: 10.1016/j.jpain.2010.03.002.

43. Manchikanti L., Falco F.J., Singh V., Benyamin R.M., Racz G.B., Helm S. 2nd et al. An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part I: introduction and general considerations. Pain Physician. 2013;16(2):1–48. Available at: https://pubmed.ncbi.nlm.nih.gov/23615882.

44. Hansen H., Manchikanti L., Simopoulos T.T., Christo P.J., Gupta S., Smith H.S. et al. A systematic evaluation of the therapeutic effectiveness of sacroiliac joint interventions. Pain Physician. 2012;15(3):E247–E278. Available at: https://pubmed.ncbi.nlm.nih.gov/22622913/.

45. Wang X., Wanyan P., Tian J.H., Hu L. Meta-analysis of randomized trials comparing fusion surgery to non-surgical treatment for discogenic chronic low back pain. J Back Musculoskelet Rehabil. 2015;28(4):621–627. doi: 10.3233/BMR-140571.

46. Bydon M., De la Garza-Ramos R., Macki M., Baker A., Gokaslan A.K., Bydon A. Lumbar fusion versus nonoperative management for treatment of discogenic low back pain: a systematic review and meta-analysis of randomized controlled trials. J Spinal Disord Tech. 2014;27(5):297–304. doi: 10.1097/BSD.0000000000000072.

47. Steffens D., Maher C.G., Pereira L.S., Stevens M.L., Oliveira V.C., Chapple M. et al. Prevention of Low Back Pain: A Systematic Review and Metaanalysis. JAMA Intern Med. 2016;176(2):199–208. doi: 10.1001/jamainternmed.2015.7431.